QNRX - PRICE - Quoin Pharmaceuticals

Quoin Pharmaceuticals (QNRX) develops therapy systems for rare dermatological pathologies, ensuring lifelong demand for its drugs. Due to the absence of direct competitors in the treatment of genetic skin disorders, the company possesses full pricing power. The price history on the GURU.Markets chart has reached the 6.41 mark. The business currently relies on external investments while awaiting the commercial launch of its developments and the completion of clinical trials.

Quoin Pharmaceuticals (QNRX) holds a monopoly position in the Niedersen syndrome therapy segment, creating a foundation for high capitalization due to a lack of competition. An analysis of historical price action allows for an assessment of the stability of this pricing power, capturing market demand dynamics and determining whether the current bullish trend maintains its strength or is entering a technical correction phase before a new stage of growth.